LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
94062-7 | Bacterial rrs gene drug resistance mutation | Prid | Pt | Isolate/Specimen | Nom | Molgen | ABXBACT | 1 | Bacterial rrs gene drug resistance mutation [Identifier] by Molecular method | Bacterial rrs drug res mut Islt/Spm | null | ACTIVE | 2.67 | 2.67 |
94063-5 | Bacterial rpsL gene drug resistance mutation | Prid | Pt | Isolate/Specimen | Nom | Molgen | ABXBACT | 1 | Bacterial rpsL gene drug resistance mutation [Identifier] by Molecular method | Bacterial rpsL drug res mut Islt/Spm | null | ACTIVE | 2.67 | 2.67 |
94064-3 | Bacterial eis gene drug resistance mutation | Prid | Pt | Isolate/Specimen | Nom | Molgen | ABXBACT | 1 | Bacterial eis gene drug resistance mutation [Identifier] by Molecular method | Bacterial eis drug res mut Islt/Spm | null | ACTIVE | 2.67 | 2.67 |
94065-0 | Bacterial rpoB gene drug resistance mutation | Prid | Pt | Isolate/Specimen | Nom | Molgen | ABXBACT | 1 | Bacterial rpoB gene drug resistance mutation [Identifier] by Molecular method | Bacterial rpoB drug res mut Islt/Spm | null | ACTIVE | 2.67 | 2.67 |
94066-8 | Person-Centered Primary Care Measure | - | Pt | ^Patient | - | PCPCM | PANEL.SURVEY.GNHLTH | 4 | Person-Centered Primary Care Measure [PCPCM] | null | null | ACTIVE | 2.67 | 2.67 |
94067-6 | Color Me Healthy - children's symptom assessment app panel | - | Pt | ^Patient | - | null | PANEL.H&P | 2 | Color Me Healthy - children's symptom assessment app | Color Me Healthy panel | Copyright © 2019 Lauri Linder. Used with permission. | ACTIVE | 2.67 | 2.71 |
94068-4 | Symptom distress level | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Symptom distress level | Symptom distress level | null | ACTIVE | 2.67 | 2.71 |
94069-2 | Emesis occurred | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Emesis occurred | Emesis occurred | null | ACTIVE | 2.67 | 2.71 |
940-7 | Bombay Ag | PrThr | Pt | RBC^BPU | Ord | null | BLDBK | 1 | Deprecated Bombay Ag [Presence] on Red Blood Cells from Blood product unit | Deprecated Bombay Ag RBC BPU Ql | null | DEPRECATED | 1.0 | 2.61 |
94070-0 | Emesis count | NRat | 24H | ^Patient | Qn | null | H&P.HX | 2 | Emesis count 24 hour | Emesis count 24h nRate | null | ACTIVE | 2.67 | 2.71 |
94072-6 | Attended school today | Find | Pt | ^Patient | Ord | null | H&P.HX | 2 | Attended school today | Attended school today | null | ACTIVE | 2.67 | 2.71 |
94073-4 | Best thing about your day | Find | Pt | ^Patient | Nom | null | H&P.HX | 2 | Best thing about your day | Best thing about your day | null | ACTIVE | 2.67 | 2.71 |
94074-2 | Most bothersome concern | Find | Pt | ^Patient | Nom | null | H&P.HX | 2 | Most bothersome concern | Most bothersome concern | null | ACTIVE | 2.67 | 2.71 |
94075-9 | Cause of sick feeling | Find | Pt | ^Patient | Nom | null | H&P.HX | 2 | Cause of sick feeling | Cause of sick feeling | null | ACTIVE | 2.67 | 2.71 |
94076-7 | Mutations/Megabase | NRto | Pt | Tumor | Qn | null | MOLPATH.MUT | 1 | Mutations/Megabase [# Ratio] in Tumor | Muts/Mb Tumor | null | ACTIVE | 2.67 | 2.67 |
94077-5 | Tumor mutation burden | Imp | Pt | Tumor | Ord | null | MOLPATH.MUT | 1 | Tumor mutation burden [Interpretation] | TMB Tumor-Imp | null | ACTIVE | 2.67 | 2.67 |
9407-8 | Alpha 1 antitrypsin | MCnc | Pt | Stool | Qn | null | CHEM | 1 | Alpha 1 antitrypsin [Mass/volume] in Stool | A1AT Stl-mCnc | null | ACTIVE | 1.0i | 2.73 |
94078-3 | PDX1 gene full mutation analysis | Prid | Pt | Bld/Tiss | Nom | Sequencing | MOLPATH.MUT | 1 | PDX1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal | PDX1 Full Mut Anl Bld/T Seq | null | ACTIVE | 2.67 | 2.67 |
94079-1 | TYMP gene full mutation analysis | Prid | Pt | Bld/Tiss | Nom | Sequencing | MOLPATH.MUT | 1 | TYMP gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal | TYMP Full Mut Anl Bld/T Seq | null | ACTIVE | 2.67 | 2.67 |
94080-9 | RRM2B gene full mutation analysis | Prid | Pt | Bld/Tiss | Nom | Sequencing | MOLPATH.MUT | 1 | RRM2B gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal | RRM2B Full Mut Anl Bld/T Seq | null | ACTIVE | 2.67 | 2.67 |
94081-7 | Validation error details | Find | Pt | Document | Doc | null | DOC.ADMIN | 2 | Validation error details Document | Validation error details Doc | null | ACTIVE | 2.67 | 2.67 |
94082-5 | Validation error summary | Find | Pt | Document | Doc | null | DOC.ADMIN | 2 | Validation error summary Document | Validation error summary Doc | null | ACTIVE | 2.67 | 2.67 |
94083-3 | Wound volume | Vol | Pt | Wound | Qn | null | H&P.HX | 2 | Wound volume | Wound vol | null | ACTIVE | 2.67 | 2.67 |
94084-1 | Nonverbal pain indicators | Find | Pt | ^Patient | Nom | null | H&P.HX | 2 | Nonverbal pain indicators | Nonverb pain ind | null | ACTIVE | 2.67 | 2.67 |
94085-8 | Pain category | Type | Pt | ^Patient | Nom | null | H&P.HX | 2 | Pain category | Pain cat | null | ACTIVE | 2.67 | 2.67 |
9408-6 | Aminobenzoate | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Aminobenzoate [Mass/volume] in Serum or Plasma | Aminobenzoate SerPl-mCnc | null | ACTIVE | 1.0i | 2.7 |
94086-6 | Wound shape | Shape | Pt | Wound | Nom | null | H&P.PX | 2 | Wound shape | Wnd shape | null | ACTIVE | 2.67 | 2.67 |
94087-4 | Chromosome analysis | Find | Pt | Bld/Tiss | Doc | Microarray | MOLPATH | 1 | Chromosome analysis in Blood or Tissue by Microarray | Chrom analy Bld/T Microarray | null | ACTIVE | 2.67 | 2.67 |
94088-2 | Multisection^WO & W contrast | Find | Pt | Chest>Spine.thoracic & Abdomen>Spine.lumbar | Doc | MR | RAD | 2 | MR Thoracic and lumbar spine WO and W contrast | MR T+L-Spine WO+W contr | null | ACTIVE | 2.67 | 2.67 |
94089-0 | Multisection^WO & W contrast IV && Multisection^W contrast IV | Find | Pt | Chest | Doc | MR && MR.angio | RAD | 2 | MR Chest WO and W contrast IV and MRA Chest W contrast IV | MR Chest WO+W contr IV+MRA W contr IV | null | ACTIVE | 2.67 | 2.67 |
94090-8 | Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty + transcatheter placement of stent | Find | Pt | XXX>Vessels | Doc | RF.angio | RAD | 2 | RFA Views for dialysis fistula W contrast IA and Guidance for percutaneous transluminal angioplasty transcatheter placement of stent | RFA dial fist W c IA + PTA + stent place | null | ACTIVE | 2.67 | 2.72 |
94091-6 | Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty | Find | Pt | XXX>Vessels | Doc | RF.angio | RAD | 2 | RFA Views for dialysis fistula W contrast IA and Guidance for percutaneous transluminal angioplasty | RFA dial fist W c IA + PTA | null | ACTIVE | 2.67 | 2.72 |
94092-4 | Views for dialysis fistula^W contrast IA | Find | Pt | XXX>Vessels | Doc | RF.angio | RAD | 2 | RFA Views for dialysis fistula W contrast IA | RFA Vs for dial fistula W contr IA | null | ACTIVE | 2.67 | 2.72 |
94093-2 | Itemized bill | Find | Pt | ^Patient | Doc | null | DOC.MISC | 2 | Itemized bill | Itemized bill | null | ACTIVE | 2.67 | 2.67 |
9409-4 | Anabolic steroids | Prid | Pt | Urine | Nom | null | CHEM | 1 | Anabolic steroids [Identifier] in Urine | Anabolic Steroids Ur | null | ACTIVE | 1.0i | 2.73 |
94094-0 | Views limited for therapy or embolization or infusion^W contrast via existing catheter | Find | Pt | XXX | Doc | RF.angio | RAD | 2 | RFA Unspecified body region Limited Views for therapy or embolization or infusion W contrast via existing catheter | RFA Vs Ltd W contr via exist cath | null | ACTIVE | 2.67 | 2.67 |
94095-7 | Views^W contrast IV | Find | Pt | Extremity.unilateral>Extremity vessels | Doc | RF.angio | RAD | 2 | RFA Extremity vessels Unilateral Views W contrast IV | RFA Ext ves-Ul Views W contr IV | null | ACTIVE | 2.67 | 2.67 |
94096-5 | Collagen type VII Ab.IgG | PrThr | Pt | Ser/Plas | Ord | IA | SERO | 1 | Collagen type VII IgG Ab [Presence] in Serum or Plasma by Immunoassay | CollagenVII IgG SerPl Ql IA | null | ACTIVE | 2.67 | 2.67 |
94097-3 | Cytosolic 5'-nucleotidase 1A Ab.IgG | PrThr | Pt | Ser/Plas | Ord | IA | SERO | 1 | Cytosolic 5'-nucleotidase 1A IgG Ab [Presence] in Serum or Plasma by Immunoassay | cN-1A IgG SerPl Ql IA | null | ACTIVE | 2.67 | 2.67 |
94098-1 | Dense fine speckled 70 protein Ab.IgG | PrThr | Pt | Ser/Plas | Ord | IA | SERO | 1 | Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Immunoassay | DFS70 IgG SerPl Ql IA | null | ACTIVE | 2.67 | 2.67 |
94099-9 | Hantavirus Ab.IgM | PrThr | Pt | Ser/Plas | Ord | IF | MICRO | 1 | Hantavirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence | Hantavirus IgM SerPl Ql IF | null | ACTIVE | 2.67 | 2.67 |
94100-5 | Hantavirus seoul Ab.IgM | PrThr | Pt | Ser/Plas | Ord | Line blot | MICRO | 1 | Hantavirus seoul IgM Ab [Presence] in Serum or Plasma by Line blot | H seoul IgM SerPl Ql Line blot | null | ACTIVE | 2.67 | 2.67 |
94101-3 | Hantavirus seoul Ab.IgG | PrThr | Pt | Ser/Plas | Ord | Line blot | MICRO | 1 | Hantavirus seoul IgG Ab [Presence] in Serum or Plasma by Line blot | H seoul IgG SerPl Ql Line blot | null | ACTIVE | 2.67 | 2.67 |
9410-2 | Histamine | MRat | 24H | Urine | Qn | null | CHEM | 1 | Histamine [Mass/time] in 24 hour Urine | Histamine 24h Ur-mRate | null | ACTIVE | 1.0i | 2.73 |
94102-1 | Epstein Barr virus early diffuse Ab.IgA | ACnc | Pt | Ser/Plas | Qn | IA | MICRO | 1 | Epstein Barr virus early diffuse IgA Ab [Units/volume] in Serum or Plasma by Immunoassay | EBV EA-D IgA SerPl IA-aCnc | null | ACTIVE | 2.67 | 2.67 |
94103-9 | Zolpidem phenyl-4-carboxylate | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | Zolpidem phenyl-4-carboxylate [Presence] in Urine by Screen method | Zolpidem phenyl-4-carb Ur Ql Scn | null | ACTIVE | 2.67 | 2.73 |
94104-7 | Zolpidem | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | Zolpidem [Presence] in Urine by Screen method | Zolpidem Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
94105-4 | Alpha hydroxytriazolam | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | Alpha hydroxytriazolam [Presence] in Urine by Screen method | A-OH-triazolam Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
94106-2 | Temazepam glucuronide | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | Temazepam glucuronide [Presence] in Urine by Screen method | Temazepam glucuronide Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
94107-0 | Oxazepam glucuronide | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | Oxazepam glucuronide [Presence] in Urine by Screen method | Oxazepam glucuronide Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
94108-8 | 1-Hydroxymidazolam | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | 1-Hydroxymidazolam [Presence] in Urine by Screen method | 1OH-midazolam Ur Ql Scn | null | ACTIVE | 2.67 | 2.73 |
94109-6 | LORazepam glucuronide | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | LORazepam glucuronide [Presence] in Urine by Screen method | LORazepam glucuronide Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
9411-0 | Hydrocorticosterone | MRat | 24H | Urine | Qn | null | CHEM | 1 | Hydrocorticosterone [Mass/time] in 24 hour Urine | Hydrocorticostern 24h Ur-mRate | null | ACTIVE | 1.0i | 2.42 |
94110-4 | 2-Hydroxyethylflurazepam | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | 2-Hydroxyethylflurazepam [Presence] in Urine by Screen method | 2-OH-Ethylfluraz Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
94111-2 | 7-Aminoflunitrazepam | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | 7-Aminoflunitrazepam [Presence] in Urine by Screen method | 7Aminoflunitrazepam Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
94112-0 | 7-Aminoclonazepam | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | 7-Aminoclonazepam [Presence] in Urine by Screen method | 7Aminoclonazepam Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
94113-8 | Norclobazam | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | Norclobazam [Presence] in Urine by Screen method | Norclobazam Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
94114-6 | cloBAZam | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | cloBAZam [Presence] in Urine by Screen method | cloBAZam Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
94115-3 | Alpha hydroxyalprazolam glucuronide | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | Alpha hydroxyalprazolam glucuronide [Presence] in Urine by Screen method | A-OH Alpraz gluc Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
94116-1 | ALPRAZolam | PrThr | Pt | Urine | Ord | Screen | DRUG/TOX | 1 | ALPRAZolam [Presence] in Urine by Screen method | Alpraz Ur Ql Scn | null | ACTIVE | 2.67 | 2.67 |
94117-9 | Benzodiazepines panel | PrThr | Pt | Urine | Ord | Screen | PANEL.DRUG/TOX | 1 | Benzodiazepines panel [Presence] - Urine by Screen method | Benzodiazepines Pnl Ur Scn | null | ACTIVE | 2.67 | 2.67 |
94118-7 | Medical records in response to authorization denial | Find | Pt | ^Patient | Doc | null | DOC.ADMIN | 2 | Medical records in response to authorization denial | Med records p auth denial | null | ACTIVE | 2.67 | 2.67 |
94119-5 | Volume.expired per minute/Carbon dioxide production^W exercise | VRto | Pt | ^Patient | Qn | null | CARDIO-PULM | 2 | Expired minute volume/Carbon dioxide production during exercise | VE/VCO2 slope dur exercise | null | ACTIVE | 2.67 | 2.67 |
94120-3 | Oxygen consumption/Heart rate^peak during exercise | VRat | Pt | ^Patient | Qn | null | CARDIO-PULM | 2 | Oxygen consumption (VO2)/Heart rate --peak during exercise | Peak oxygen pulse | null | ACTIVE | 2.67 | 2.67 |
94121-1 | Intravascular | Pres | Pt | Vena cava.inferior | Qn | US | BP.VENOUS.MOLEC | 2 | Inferior vena cava Blood pressure by US | IVC BP by US | null | ACTIVE | 2.67 | 2.67 |
94122-9 | Oxygen consumption/Body weight^peak during exercise | VRatCnt | Pt | ^Patient | Qn | null | PULM | 2 | Oxygen consumption (VO2)/Body weight [Volume Rate Content] --peak during exercise | VO2/BW max dur exercise | null | ACTIVE | 2.67 | 2.67 |
94123-7 | Intravascular end diastolic | Pres | Pt | Pulmonary artery | Qn | Cardiac catheterization | BP.CENT.MOLEC | 2 | Pulmonary artery End diastolic blood pressure by Cardiac catheterization | dPAP by Cardiac cath | null | ACTIVE | 2.67 | 2.67 |
94124-5 | Ventilatory threshold | VRatCnt | Pt | ^Patient | Qn | null | PULM | 2 | Ventilatory threshold [Volume Rate Content] | Ventilatory threshold | null | ACTIVE | 2.67 | 2.67 |
94125-2 | Volume.residual/Predicted | VFr | Pt | Respiratory system | Qn | Plethysmograph.body box | PULM | 2 | Residual volume/Predicted by Plethysmograph body box | Residual vol/Predicted Plethysmograph | null | ACTIVE | 2.67 | 2.67 |
94126-0 | Ventilatory equivalent for carbon dioxide^W exercise | VRto | Pt | ^Patient | Qn | null | PULM | 2 | Ventilatory equivalent for carbon dioxide --W exercise | VEqCO2 W exercise | null | ACTIVE | 2.67 | 2.67 |
94127-8 | Clarity | Type | Pt | Body fld | Nom | null | SPEC | 1 | Clarity of Body fluid | Clarity Fld | null | ACTIVE | 2.67 | 2.67 |
9412-8 | Leucine | SCnc | Pt | CSF | Qn | null | CHEM | 1 | Leucine [Moles/volume] in Cerebral spinal fluid | Leucine CSF-sCnc | null | ACTIVE | 1.0i | 2.73 |
94128-6 | Vasopressin challenge post water deprivation panel | - | Pt | Urine+Ser/Plas | - | null | PANEL.CHAL | 1 | Vasopressin challenge post water deprivation panel - Urine and Serum or Plasma | Vasopressin chal p H2O depr Pnl U+SerPl | null | ACTIVE | 2.67 | 2.67 |
94129-4 | Water deprivation challenge panel | - | Pt | Urine+Ser/Plas | - | null | PANEL.CHAL | 1 | Water deprivation challenge panel - Urine and Serum or Plasma | Water deprivation Pnl Ur+SerPl | null | ACTIVE | 2.67 | 2.67 |
94130-2 | Body disposition facility name | ID | Pt | Facility | Nom | null | ADMIN.FACILITY | 2 | Body disposition facility name [Identifier] | Body disposition facility name | null | ACTIVE | 2.67 | 2.67 |
94131-0 | Body disposition facility address | Addr | Pt | Facility | Nom | null | ADMIN.FACILITY | 2 | Body disposition facility address | Body disposition facility address | null | ACTIVE | 2.67 | 2.67 |
94132-8 | Funeral facility name | ID | Pt | Facility | Nom | null | ADMIN.FACILITY | 2 | Funeral facility name [Identifier] | Funeral facility name | null | ACTIVE | 2.67 | 2.67 |
94133-6 | Funeral facility address | Addr | Pt | Facility | Nom | null | ADMIN.FACILITY | 2 | Funeral facility address | Funeral facility address | null | ACTIVE | 2.67 | 2.67 |
94134-4 | Funeral service licensee or other agent assuming custody of the body of the deceased | Pn | Pt | Personnel | Nom | null | ADMIN.FACILITY | 2 | Personnel Funeral service licensee or other agent assuming custody of the body of the deceased | Personnel Funeral service licensee | null | ACTIVE | 2.67 | 2.67 |
94135-1 | Funeral service licensee identifier | ID | Pt | Facility | Nom | null | ADMIN.FACILITY | 2 | Funeral service licensee identifier Facility | Funeral service licensee ID Facility | null | ACTIVE | 2.67 | 2.67 |
9413-6 | Lipids | MRat | 24H | Stool | Qn | null | CHEM | 1 | Deprecated Lipids [Mass/time] in 24 hour Stool | Deprecated Lipids 24h Stl-mRate | null | DEPRECATED | 1.0i | 2.7 |
94136-9 | Controlled substance agreement | Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | Controlled substance agreement | Cntrl Substance Agreement | null | ACTIVE | 2.67 | 2.67 |
94137-7 | HEDIS 2020 Value Sets | - | Pt | ^Patient | - | null | PANEL.HEDIS | 1 | HEDIS 2020 Value Sets | HEDIS 2020 Value Sets | null | DISCOURAGED | 2.67 | 2.69 |
94138-5 | HEDIS 2020 Value Set - BMI | - | Pt | ^Patient | - | null | PANEL.HEDIS | 1 | HEDIS 2020 Value Set - BMI | HEDIS 2020 BMI | null | DISCOURAGED | 2.67 | 2.69 |
94139-3 | HEDIS 2020 Value Set - BMI percentile | - | Pt | ^Patient | - | null | PANEL.HEDIS | 1 | HEDIS 2020 Value Set - BMI percentile | HEDIS 2020 BMI prctl | null | DISCOURAGED | 2.67 | 2.69 |
94140-1 | HEDIS 2020 Value Set - CT Colonography | - | Pt | ^Patient | - | null | PANEL.HEDIS | 1 | HEDIS 2020 Value Set - CT Colonography | HEDIS 2020 CT Colongrphy | null | DISCOURAGED | 2.67 | 2.69 |
94141-9 | HEDIS 2020 Value Set - Mammography | - | Pt | ^Patient | - | null | PANEL.HEDIS | 1 | HEDIS 2020 Value Set - Mammography | HEDIS 2020 Mammography | null | DISCOURAGED | 2.67 | 2.69 |
94142-7 | HEDIS 2020 Value Set - Urine Protein Tests | - | Pt | ^Patient | - | null | PANEL.HEDIS | 1 | HEDIS 2020 Value Set - Urine Protein Tests | HEDIS 2020 Urine Prot Tests | null | DISCOURAGED | 2.67 | 2.69 |
94143-5 | HEDIS 2020 Value Set - Diastolic Blood Pressure | - | Pt | ^Patient | - | null | PANEL.HEDIS | 1 | HEDIS 2020 Value Set - Diastolic Blood Pressure | HEDIS 2020 Diastolic BP | null | DISCOURAGED | 2.67 | 2.69 |
9414-4 | Phosphoserine | SCnc | 24H | Urine | Qn | null | CHEM | 1 | Phosphoserine [Moles/volume] in 24 hour Urine | Phosphoserine 24h Ur-sCnc | null | ACTIVE | 1.0i | 2.73 |
94144-3 | HEDIS 2020 Value Set - Systolic Blood Pressure | - | Pt | ^Patient | - | null | PANEL.HEDIS | 1 | HEDIS 2020 Value Set - Systolic Blood Pressure | HEDIS 2020 Systolic BP | null | DISCOURAGED | 2.67 | 2.69 |
94145-0 | Crotonylglycine/Creatinine | SRto | Pt | Urine | Qn | null | CHEM | 1 | Crotonylglycine/Creatinine [Molar ratio] in Urine | Crotonylglycine/Creat Ur-sRto | null | ACTIVE | 2.68 | 2.68 |
94146-8 | 2-Decenedioate/Creatinine | SRto | Pt | Urine | Qn | null | CHEM | 1 | 2-Decenedioate/Creatinine [Molar ratio] in Urine | 2-Decenedioate/Creat Ur-sRto | null | ACTIVE | 2.68 | 2.68 |
94147-6 | B-bump | Find | Pt | Mitral valve | Ord | US.M-mode | CARD.US | 2 | Mitral valve B-bump by US.M-mode | MV B-bump M-mode | null | ACTIVE | 2.68 | 2.68 |
94148-4 | Blood flow reversal.holodiastolic | Find | Pt | Aorta.thoracic.descending | Ord | US.doppler | CARD.US | 2 | Descending thoracic aorta Holodiastolic flow reversal by US.doppler | DTA Holodias flow reversal DOP | null | ACTIVE | 2.68 | 2.68 |
94149-2 | Heterophile Ab | PrThr | Pt | Ser/Plas/Bld | Ord | IA.rapid | MICRO | 1 | Heterophile Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | Heteroph Ab SerPlBld Ql IA.rapid | null | ACTIVE | 2.68 | 2.68 |
941-5 | Bombay Ag | PrThr | Pt | RBC^Donor | Ord | null | BLDBK | 1 | Deprecated Bombay Ag [Presence] on Red Blood Cells from donor | Deprecated Bombay Ag RBC Donr Ql | null | DEPRECATED | 1.0 | 2.61 |
9415-1 | carBAMazepine 10,11-Epoxide | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Carbamazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma | Carbamazepine EP SerPl-mCnc | null | ACTIVE | 1.0i | 2.73 |
94151-8 | Bacteria.carbapenem resistant identified | Prid | Pt | XXX | Nom | Organism specific culture | MICRO | 1 | Bacteria.carbapenem resistant identified in Specimen by Organism specific culture | Bacteria.carbpm resist Spec Cult | null | ACTIVE | 2.68 | 2.69 |
94157-5 | PhenX - age of initiation of first cigarette use - adult protocol 030703 | - | Pt | ^Patient | - | PhenX | PANEL.PHENX | 2 | PhenX - age of initiation of first cigarette use - adult protocol 030703 | Age init cig use adult proto | null | ACTIVE | 2.68 | 2.68 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.